CM
MDCO

Castleark Management’s Medicines Co MDCO Stock Holding History

Castleark Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-228,495
Closed -$8.62M – 434
2016
Q3 		$8.62M Buy
+228,495
New +$8.61M 0.26% 119
2014
Q1 		– Sell
-204,445
Closed -$7.9M – 350
2013
Q4 		$7.9M Buy
+204,445
New +$7.31M 0.23% 79

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Castleark Management's MDCO Position: Q4 2016 in Review

Castleark Management sold out of Medicines Co (MDCO) in Q4 2016, closing a stake of 228,495 shares — an estimated $8.62M sold.

Castleark Management first reported a position in MDCO in Q4 2013 and held it in 2 quarters. The position peaked at $8.62M in Q3 2016. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

  • Castleark Management reported no remaining Medicines Co position as of Q4 2016 after selling out during the quarter.
  • Castleark Management sold 228,495 Medicines Co shares in Q4 2016, an estimated $8.62M.
  • Castleark Management first reported a position in Medicines Co in Q4 2013 and held it in 2 quarters.
  • Castleark Management's Medicines Co position peaked at $8.62M in Q3 2016.
  • 195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on Castleark Management's 13F filing for Q4 2016, filed 15 Feb 2017.